christian angermayer

T2 · manager / operator

German serial entrepreneur and investor who co-founded Alnylam Pharmaceuticals at age 20, founded Atai Life Sciences to bring psychedelic medicines to psychiatry, co-founded Compass Pathways, and launched Enhanced Games as a performance-enhancing drug-permitted sports league. Runs family office Apeiron Investment Group.

5 calls·5 names·80% bull·last heard 3 months ago·Generating Alpha Podcast
track record

no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY

top calls

highest conviction · one per company
1sthigh conviction
$ENHEnhanced Gamesposition

Angermayer backs Enhanced Games: medical PEDs as recovery tools for athletes

FDA-approved performance-enhancing drugs under medical supervision help athletes recover from sport-induced bodily damage; Enhanced Games runs clinical trials to prove safety and efficacy, shifting the moral debate and potentially changing global sports policy within 3 years.

2ndhigh conviction
$ATAIAtai Life Sciencesposition

Angermayer's main holding Atai brings psychedelic medicines to mainstream psychiatry

Psychedelic compounds have near-zero downside when used medically with clinicians and can cure mental health issues; Atai is building the full suite of psychedelic medicines with first approvals expected early next year.

3rdhigh conviction
$CMPSCompass Pathwaysposition

Angermayer seeded Compass Pathways, invested $1.5B proving psilocybin efficacy

Psilocybin can treat mental health with low doses; Compass proved the 1960s science works in modern trials, de-risking the entire psychedelic medicine category.

5 total
$ENH
···
Enhanced Games
HIGHchristian angermayer·Generating Alpha Podcast·3 months ago· position
Angermayer backs Enhanced Games: medical PEDs as recovery tools for athletes
FDA-approved performance-enhancing drugs under medical supervision help athletes recover from sport-induced bodily damage; Enhanced Games runs clinical trials to prove safety and efficacy, shifting the moral debate and potentially changing global sports policy within 3 years.
"Aaron sort of this idea of the enhanced games was so much grounded in science because like meaning it starts that the other what we probably the Olympics like is the most intransp…"
44:35
$ATAI
···
Atai Life Sciences
HIGHchristian angermayer·Generating Alpha Podcast·3 months ago· position
Angermayer's main holding Atai brings psychedelic medicines to mainstream psychiatry
Psychedelic compounds have near-zero downside when used medically with clinicians and can cure mental health issues; Atai is building the full suite of psychedelic medicines with first approvals expected early next year.
"my main holding is is atai stock market listed. What I What we're doing now is bringing back various psychedelic medicines into the medical world. So, I don't want people to try i…"
15:45
$CMPS
···
Compass Pathways
HIGHchristian angermayer·Generating Alpha Podcast·3 months ago· position
Angermayer seeded Compass Pathways, invested $1.5B proving psilocybin efficacy
Psilocybin can treat mental health with low doses; Compass proved the 1960s science works in modern trials, de-risking the entire psychedelic medicine category.
"we just invested 1 and 1/2 billion with a tiny compass and we've proven that psychedelics work with fairly low doses. And the same when I looked at at Aaron's idea of enhanced gam…"
45:53
$ALNY
···
Alnylam Pharmaceuticals
HIGHchristian angermayer·Generating Alpha Podcast·3 months ago· position
Angermayer co-founded Alnylam on RNAi thesis, took public via SPAC at 25
RNAi technology could switch off genetic disease expression at the root cause, addressing a multi-billion dollar market with no existing treatments for genetic diseases.
"Now, it's called RNAi. Um and they talked about it. And I also want to admit like I understood only vaguely where they want to go, but I had a good feeling for Oh, wow, I think I…"
6:12
$APEIRON-INVESTMENT-GROUP
Apeiron Investment Group
HIGHchristian angermayer·Generating Alpha Podcast·3 months ago· position
Angermayer's family office Apeiron invests across lifecycle, seeds funds, and builds companies
Apeiron manages Angermayer's capital plus outside money, doing direct investments from seed to public equities, investing in third-party funds for diversification, and incubating unique companies like Atai and Enhanced Games where the firm's network provides unfair advantage.
"Atai is my is is both. So, we we So, it's my family office. So, a big part of the capital we manage is my own capital, but we also sponsor funds which we then manage. So, we also…"
28:31